Authors
Latest:
Synergies in Specialty: The 3 P's of Specialty Pharmacy--Pharmacy, Payer, and ProductIn the development of a specialty pharmacy strategy, there are many key stakeholders, but none more important than the pharmacy, payer, and product. Each has its own mission and goals; however, at some point they must all come together.
Latest:
Offer Patients Counseling on ADFsPharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.
Latest:
Improve Medication Adherence in Patients with HIVPharmacists can motivate patients to stick to their drug regimens to decrease viral load and prevent further transmission.
Latest:
Securing Specialty Oncology Contracts in a Data-Driven WorldData aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
Latest:
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia SyndromeWhile fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
Latest:
Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s OpportunityThis Continuing Education activity is supported by an educational grant from Sandoz Inc.
Latest:
Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan PopulationBuprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Latest:
NAPLEX Preparation: Tips for the Most Important Exam of Your CareerBefore you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.
Latest:
Lifelong Learning in Specialty Pharmacy Goes Beyond Continuing Education RequirementsRecent pharmacy school graduates will find the benefits of investing in professional development to open new career paths.
Latest:
Bleeding Disorder Management at a Health System Specialty Pharmacy Improves Quality of LifeHigh-cost medications necessary for treatment require close management to ensure patient safety and to adhere to payer-specific requirements.
Latest:
Practicing Pharmacy Across the PacificAs a first-year student pharmacist, I was initially overwhelmed by the number of student organizations and opportunities to get involved.
Latest:
Importance of Sickle Cell Awareness Month Highlighted by Lack of Funding, Treatment OptionsSeptember has been designated as National Sickle Cell Awareness Month for the continued fostering of education surrounding sickle cell disease management.
Latest:
Workplace Stress Was Highest Among Younger Employees During COVID-19 PandemicStudy finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.
Latest:
Budget Impact of Everolimus in Treating Metastatic Renal Cell CarcinomaA decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Latest:
Persistence With Antiarrhythmics and the Impact on Atrial Fibrillation–Related OutcomesRetrospective analysis of claims data showed that persistence with amiodarone and sotalol was generally poor.
Latest:
Comparison of Pharmacists and Primary Care Providers as ImmunizersPharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
Latest:
Palliative Care: The Role of the PharmacistPharmacists are essential in developing an individualized treatment regimen for each patient.
Latest:
Does Medication Persistence in Diabetes Affect the Risk Of Hospitalization In The Short-Term?An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.
Latest:
Telepharmacy and Its Impact on Formulary AdherenceTelepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.
Latest:
Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ HydrochlorothiazideInitial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.
Latest:
CVS Caremark's View of Oncology Drug Management, Part 2CVS Caremark is expanding into the realm of specialty oncology management for drugs covered under the medical benefit and traditionally administered in physician offices or clinics
Latest:
Living Well: The Science of Postponing AgingCompression of morbidity is achieved through the reduction of behavioral risks.
Latest:
New Approaches to Defining and Measuring the Quality of HealthcareConference coverage of the 2012 meeting of the American Diabetes Association.
